almagate has been researched along with Retinal Detachment in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, P; Sankar, J; Sankar, MJ | 1 |
| Nuzzi, R; Tridico, F | 1 |
| Kobayashi, M; Manabe, S; Ono, A; Shiraga, F; Shiragami, C; Yamashita, A | 1 |
| Bhat, V; Mehta, M; Sankar, J; Sankar, MJ; Srinivasan, R | 1 |
| Goverdhan, S; Krishnan, R; Lochhead, J | 1 |
| Chang, LK; Chiang, A; Sarraf, D; Yu, F | 1 |
| Calvo-González, C; Donate-López, J; García-Feijoó, J; García-Sánchez, J; Leila, M; Molina Guilabert, I; Reche-Frutos, J | 1 |
| Gutfleisch, M; Heimes, B; Lommatzsch, AP; Pauleikhoff, D; Spital, G; Zeimer, M | 1 |
| Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A | 1 |
| Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G; Zeimer, M | 1 |
| Dietzel, M; Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G | 1 |
| Gelisken, F; Ziemssen, F | 1 |
| Acquah, K; Day, S; Grossman, DS; Lee, PP; Mruthyunjaya, P; Sloan, FA | 1 |
| Bird, A; Dietzel, M; Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Schumacher, M | 1 |
| Apte, RS; Blinder, KJ; Dhalla, MS; Hariprasad, SM; Tewari, A | 1 |
| Heimann, H; Meyer, CH; Ziemssen, F | 1 |
4 review(s) available for almagate and Retinal Detachment
| Article | Year |
|---|---|
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Combined Modality Therapy; Cryotherapy; Humans; Infant, Newborn; Intravitreal Injections; Laser Therapy; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Detachment; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A | 2018 |
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Bevacizumab; Combined Modality Therapy; Cryotherapy; Humans; Infant, Newborn; Intravitreal Injections; Laser Therapy; Randomized Controlled Trials as Topic; Retinal Detachment; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A | 2016 |
[Diabetic maculopathy. Diagnosis and treatment].
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Glycated Hemoglobin; Humans; Intravitreal Injections; Ischemia; Laser Coagulation; Macular Edema; Ophthalmoscopy; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2010 |
[Intravitreal injection. Monitoring to avoid postoperative complications].
Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Cataract; Clinical Trials, Phase III as Topic; Endophthalmitis; Eye Hemorrhage; Female; Fetus; Hallucinations; Humans; Injections; Intraocular Pressure; Macular Degeneration; Mice; Paracentesis; Postoperative Complications; Pregnancy; Rabbits; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Detachment; Uveitis; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
1 trial(s) available for almagate and Retinal Detachment
| Article | Year |
|---|---|
[Treatment of vascularised serous pigment epithelium detachment in AMD - observations after changing the intravitreal agent due to lack of response].
Topics: Aged; Aptamers, Nucleotide; Dose-Response Relationship, Drug; Female; Humans; Macular Degeneration; Male; Retinal Detachment; Treatment Outcome; Vascular Endothelial Growth Factor A | 2008 |
11 other study(ies) available for almagate and Retinal Detachment
| Article | Year |
|---|---|
Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Female; Follow-Up Studies; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Odds Ratio; Ranibizumab; Retinal Detachment; Retinal Diseases; Retinal Hemorrhage; Retrospective Studies; Uveitis; Vascular Endothelial Growth Factor A | 2015 |
Effect of switching therapy to pegaptanib in eyes with the persistent cases of exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Combined Modality Therapy; Drug Substitution; Exudates and Transudates; Female; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Photochemotherapy; Prospective Studies; Radiography; Ranibizumab; Retina; Retinal Detachment; Tomography, Optical Coherence; Treatment Failure; Visual Acuity | 2014 |
Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment.
Topics: Adult; Aptamers, Nucleotide; Diabetic Retinopathy; Disease Progression; Female; Humans; Intravitreal Injections; Middle Aged; Retinal Detachment; Visual Acuity | 2009 |
Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Macular Degeneration; Male; Predictive Value of Tests; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Pigment Epithelium; Retinal Vessels; Retrospective Studies; Risk Assessment; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A | 2008 |
Intravitreal pegabtanib sodium in choroidal neovascularization secondary to angioid streaks.
Topics: Adult; Angiogenesis Inhibitors; Angioid Streaks; Aptamers, Nucleotide; Choroidal Neovascularization; Edema; Fluorescein Angiography; Humans; Injections; Male; Retinal Detachment; Retinal Diseases; Tomography, Optical Coherence; Vitreous Body | 2009 |
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage | 2008 |
Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Immunologic Factors; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Pigment Epithelium of Eye; Ranibizumab; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2009 |
[Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Ophthalmoscopes; Ranibizumab; Retina; Retinal Detachment; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Case-Control Studies; Endophthalmitis; Eye Diseases; Female; Follow-Up Studies; Health Services Research; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Male; Medicare Part B; Proportional Hazards Models; Ranibizumab; Retinal Detachment; Retinal Perforations; Retrospective Studies; United States; Uveitis; Vascular Endothelial Growth Factor A; Vitreous Hemorrhage | 2011 |
Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Female; Fluorescein Angiography; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Pigment Epithelium of Eye; Ranibizumab; Retinal Detachment; Retinal Perforations; Tomography, Optical Coherence; Vascular Endothelial Growth Factors; Visual Acuity | 2011 |
Retinal pigment epithelial tear following intravitreal pegaptanib sodium.
Topics: Aged; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Pigment Epithelium of Eye; Retinal Detachment; Retinal Perforations; Tomography, Optical Coherence; Visual Acuity | 2006 |